Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: A pre-specified analysis from the prodigy study (prolonging dual antiplatelet treatment after grading stent-induced intimal hyperplasia study)